You are here: Industry Insights > Parkinson's

News List

Psychobiotic PS128 consumption shows benefits to Parkinson's symptoms in new clinical study prnasia
February 19, 2021
Bened Biomedical, a leading Taiwan, Chinaese probiotic company, has announced a successful clinical study for its PS128 psychobiotic in treating symptoms of Parkinson's disease (PD).
China National Medical Products Administration Approves MR-guided Focused Ultrasound To Treat Essential Tremor And Tremor-dominant Parkinson's Disease prnasia
February 10, 2021
Insightec®, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by The National Medical Products Administration (NMPA), the Chinese agency for regulating drugs and medical devices ...
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials prnasia
February 10, 2021
Alterity Therapeutics has announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine optimal dosing of its lead drug candidate ATH434 for Parkinson's disease (PD) based on imaging of brain iron.
Lilly to Acquire Prevail Therapeutics in $1B Deal contractpharma
December 16, 2020
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.
Sanofi, Parkinson's Foundation to Advance Availability of Genetic Testing for Parkinson's americanpharmaceuticalreview
October 23, 2020
Sanofi and the Parkinson's Foundation announced a new research collaboration to advance the availability of genetic testing and counseling for people living with Parkinson's disease in the U.S. Over the next two years, Sanofi will provide $1 million ...
Gene Therapy Forms New Polysynaptic Pathways in Parkinson's drugs
November 29, 2018
For patients with Parkinson's disease (PD) undergoing gene therapy, new polysynaptic functional pathways develop in the brain, according to a study published in the Nov. 28 issue of Science Translational Medicine.
Verge Genomics: employing AI to improve drug discovery pharmaceutical
November 19, 2018
Artificial Intelligence (AI) and machine learning has begun to dominate innovation in the medical field with the help of an increasing quantity and quality of data. For example...
Lundbeck snaps up Parkinson’s candidate via Prexton buy pharmatimes
July 23, 2018
Lundbeck has announced plans to buy Prexton Therapeutics in a deal valued at up to 905 million euros.
A protein linking Parkinson's and tuberculosis could spur better drugs for both fiercebiotech
May 29, 2018
A team of scientists has discovered that an immune mechanism that clears bacterial infections may also play a role in causing Parkinson's disease.
FDA approves Parkinson's disease drug cphi-online
March 27, 2017
First NCE approved for PD patients with motor fluctuations in the US in more than a decade.

Previous page 1 2 3 Next page